Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Grant Will Fuel Development of Lab-Grown Mini Tumors for Rare Cancers
Original story from UCLA Jonsson Comprehensive Cancer Center READ ARTICLE BY SELECTING HERE.
Prof Was Mansoor discusses treatments of Lung Neuroendocrine Cancers
Hear Prof Was Mansoor of The Christie NHS Foundation Trust, as he discusses the way forward for the treatment of Lung #NeuroendocrineCancer particularly with regard to Typical & Atypical tumours. ➡️ https://vimeo.com/613602643 #NeuroendocrineCancer #NETCancer...
Thyroid Cancer
September is Thyroid Cancer Awareness Month. Medullary Thyroid Cancer (MTC) is a rare neuroendocrine cancer that accounts for about 7 in 100 cases of thyroid cancer. In 25% of MTC - it can occur as part of rare inherited (genetic) disorders called MEN2 or MEN3. ...